Literature DB >> 15556119

Three-year outcomes of long-term patients with co-occurring bipolar and substance use disorders.

Robert E Drake1, Haiyi Xie, Gregory J McHugo, Martha Shumway.   

Abstract

Little is known about the long-term outcomes of patients in the public mental health system who are disabled by co-occurring bipolar and substance use disorders. This article reports on the 3-year course of 51 patients with co-occurring bipolar and substance use disorders in the New Hampshire Dual Diagnosis Study. Participants received integrated dual disorders treatments in the state mental health system and were independently assessed with standardized measures at baseline and every 6 months for 3 years. Though psychiatric symptoms improved only modestly, participants improved steadily in terms of remission from substance abuse (61% in full remission at 3 years); they also achieved greater independent living (average 239 days in third year), competitive employment (49% in third year), regular social contacts with nonsubstance abusers (46% at 3 years), and quality of life (56% satisfied with life at 3 years). Different domains of outcome were only weakly related to each other. Long-term, disabled patients with co-occurring bipolar and substance use disorders have potential for remission from substance abuse and substantial improvements in functioning and quality of life.

Entities:  

Mesh:

Year:  2004        PMID: 15556119     DOI: 10.1016/j.biopsych.2004.08.020

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  18 in total

1.  Long-term sobriety strategies for men with co-occurring disorders.

Authors:  Alison Luciano; Elisabeth L Bryan; Elizabeth A Carpenter-Song; Mary Woods; Katherine Armstrong; Robert E Drake
Journal:  J Dual Diagn       Date:  2014

2.  Impact of depressive symptoms on future alcohol use in patients with co-occurring bipolar disorder and alcohol dependence: a prospective analysis in an 8-week randomized controlled trial of acamprosate.

Authors:  James J Prisciandaro; Stacia M DeSantis; Cody Chiuzan; Delisa G Brown; Kathleen T Brady; Bryan K Tolliver
Journal:  Alcohol Clin Exp Res       Date:  2011-09-20       Impact factor: 3.455

3.  Management of persons with co-occurring severe mental illness and substance use disorder: program implications.

Authors:  Robert E Drake; Kim T Mueser; Mary F Brunette
Journal:  World Psychiatry       Date:  2007-10       Impact factor: 49.548

4.  Predictors of incarceration among urban adults with co-occurring severe mental illness and a substance use disorder.

Authors:  Alison Luciano; Johannes Belstock; Per Malmberg; Gregory J McHugo; Robert E Drake; Haiyi Xie; Susan M Essock; Nancy H Covell
Journal:  Psychiatr Serv       Date:  2014-10-31       Impact factor: 3.084

5.  Characterizing the longitudinal patterns of substance use among individuals diagnosed with serious mental illness after psychiatric hospitalization.

Authors:  Amber L Bahorik; Christina E Newhill; Shaun M Eack
Journal:  Addiction       Date:  2013-03-28       Impact factor: 6.526

6.  Integrated treatment for jail recidivists with co-occurring psychiatric and substance use disorders.

Authors:  Daniel William Chandler; Gary Spicer
Journal:  Community Ment Health J       Date:  2006-08-24

7.  Is Capability to Manage Finances Stable Over Time?

Authors:  Christina M Lazar; Anne C Black; Marc I Rosen
Journal:  Am J Psychiatr Rehabil       Date:  2018 Fall-Winter

8.  Clozapine use and relapses of substance use disorder among patients with co-occurring schizophrenia and substance use disorders.

Authors:  Mary F Brunette; Robert E Drake; Haiyi Xie; Gregory J McHugo; Alan I Green
Journal:  Schizophr Bull       Date:  2006-06-16       Impact factor: 9.306

9.  Housing Preferences among Adults with Dual Diagnoses in Different Stages of Treatment and Housing Types.

Authors:  Jack Tsai; Gary R Bond; Kristin E Davis
Journal:  Am J Psychiatr Rehabil       Date:  2010-10-01

10.  The association of psychiatric comorbidity with treatment completion among clients admitted to substance use treatment programs in a U.S. national sample.

Authors:  Noa Krawczyk; Kenneth A Feder; Brendan Saloner; Rosa M Crum; Marc Kealhofer; Ramin Mojtabai
Journal:  Drug Alcohol Depend       Date:  2017-04-19       Impact factor: 4.492

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.